Laurie Keating - Net Worth and Insider Trading
Laurie Keating Net Worth
The estimated net worth of Laurie Keating is at least $1 Million dollars as of 2024-05-01. Laurie Keating is the EVP, Chief Legal Officer of Alnylam Pharmaceuticals Inc and owns about 5,566 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $813,527. Laurie Keating is the SVP, GC & Secretary of Alkermes PLC and owns about 11,757 shares of Alkermes PLC (ALKS) stock worth over $280,287. Laurie Keating is also the Director of PepGen Inc and owns about 4,166 shares of PepGen Inc (PEPG) stock worth over $55,408. Besides these, Laurie Keating also holds Immuneering Corp (IMRX) . Details can be seen in Laurie Keating's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Laurie Keating has not made any transactions after 2022-05-16 and currently still holds the listed stock(s).
Transaction Summary of Laurie Keating
Laurie Keating Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laurie Keating owns 4 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Imago BioSciences Inc (IMGO) , and Immuneering Corp (IMRX) among others .
Click here to see the complete history of Laurie Keating’s form 4 insider trades.
Insider Ownership Summary of Laurie Keating
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2021-08-05 | SVP,GC & Secretary |
| IMGO | Imago BioSciences Inc | 2021-11-17 | director |
| IMRX | Immuneering Corp | 2022-05-16 | director |
| PEPG | PepGen Inc | 2022-05-06 | director |
Laurie Keating Latest Holdings Summary
Laurie Keating currently owns a total of 4 stocks. Among these stocks, Laurie Keating owns 5,566 shares of Alnylam Pharmaceuticals Inc (ALNY) as of August 5, 2021, with a value of $813,527 and a weighting of 69.61%. Laurie Keating owns 11,757 shares of Alkermes PLC (ALKS) as of December 20, 2017, with a value of $280,287 and a weighting of 23.98%. Laurie Keating also owns 4,166 shares of PepGen Inc (PEPG) as of May 6, 2022, with a value of $55,408 and a weighting of 4.74%. The other 1 stocks Immuneering Corp (IMRX) have a combined weighting of 1.67% among all his current holdings.
Latest Holdings of Laurie Keating
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2021-08-05 | 5,566 | 146.16 | 813,527 |
| ALKS | Alkermes PLC | 2017-12-20 | 11,757 | 23.84 | 280,287 |
| PEPG | PepGen Inc | 2022-05-06 | 4,166 | 13.30 | 55,408 |
| IMRX | Immuneering Corp | 2022-05-16 | 14,000 | 1.39 | 19,460 |
Holding Weightings of Laurie Keating
Laurie Keating Form 4 Trading Tracker
According to the SEC Form 4 filings, Laurie Keating has made a total of 10 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 10,000 shares on August 5, 2021, which brought Laurie Keating around $2 Million.
According to the SEC Form 4 filings, Laurie Keating has made a total of 0 transactions in Alkermes PLC (ALKS) over the past 5 years. The most-recent trade in Alkermes PLC is the sale of 6,249 shares on December 20, 2017, which brought Laurie Keating around $757,379.
According to the SEC Form 4 filings, Laurie Keating has made a total of 1 transactions in PepGen Inc (PEPG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PepGen Inc is the acquisition of 4,166 shares on May 6, 2022, which cost Laurie Keating around $49,992.
More details on Laurie Keating's insider transactions can be found in the Insider Trading History of Laurie Keating table.Insider Trading History of Laurie Keating
- 1
Laurie Keating Trading Performance
GuruFocus tracks the stock performance after each of Laurie Keating's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laurie Keating is 31.64%. GuruFocus also compares Laurie Keating's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laurie Keating within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Laurie Keating's insider trading performs compared to the benchmark.
Performance of Laurie Keating
Average Return
21.91%
Outperforming Transactions
75%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.42 | 31.64 | 19.84 | 21.91 | -11.67 | 28.27 |
| Relative Return to S&P 500(%) | 13.82 | 27.85 | 19.54 | 19.49 | -15.87 | 20.21 |
Laurie Keating Ownership Network
Ownership Network List of Laurie Keating
Ownership Network Relation of Laurie Keating
Laurie Keating Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Laurie Keating is the SVP,GC & Secretary of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Tolga Tanguler , CMO & EVP Dev & Med Affairs Pushkal Garg , and EVP & CLO & Secretary Indrani Lall Franchini .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Laurie Keating made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 30,567 shares made by Pushkal Garg , a net sale of 7,095 shares made by Indrani Lall Franchini , and a net sale of 14,604 shares made by Yvonne Greenstreet .
In summary, during the past 3 months, insiders sold 36,501 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 36,501 shares. During the past 18 months, 159,676 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,676 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Laurie Keating Mailing Address
Above is the net worth, insider trading, and ownership report for Laurie Keating. You might contact Laurie Keating via mailing address: 300 Third Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
